Combined transplantation of hiPSC-NSC and hMSC ameliorated neuroinflammation and promoted neuroregeneration in acute spinal cord injury.

"Declarations Ethics approval and consent to participateThe human PBMC collections and animal studies protocol were approved by the Committee of Ethics on Experimentation of Hebei Medical University (Assurance No. 20190505). Informed consent was obtained from all participants involved in the study. Title of an ethical approved project: Efficacy and mechanism of human iPSC derived neural stem cells in the treatment of spinal cord injury. Date of approval May 5, 2019. The experiments were conducted in accordance with the ARRIVE guidelines (http://www.nc3rs.org.uk/page.asp?id=1357) for the care and use of animals. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Funded by Natural Science Foundation of China (81801278), China Scholarship Council (201608130015), Natural Science Foundation of Hebei Province (H2019206637), Key Natural Science Foundation of Hebei Province (H2020206557), Overseas researcher Program in Hebei Provincial Department of human resources and social security (C20190509), Natural Science Foundation of Hebei Province (H2015206409), Natural Science Foundation of Hebei Province (H2023206266)."